Cart
sales@molnova.com
Home - Products - GPCR/G Protein - Prostaglandin Receptor - Isbogrel

Isbogrel

CAS No. 89667-40-3

Isbogrel( —— )

Catalog No. M34289 CAS No. 89667-40-3

Isbogrel (CV4151) is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor that can be used to study cardiac arrhythmias, transient ischemic attacks and thrombosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 472 In Stock
10MG 644 In Stock
25MG 905 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Isbogrel
  • Note
    Research use only, not for human use.
  • Brief Description
    Isbogrel (CV4151) is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor that can be used to study cardiac arrhythmias, transient ischemic attacks and thrombosis.
  • Description
    Isbogrel (CV4151) is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor that can be used to study cardiac arrhythmias, transient ischemic attacks and thrombosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Prostaglandin Receptor
  • Recptor
    Prostaglandin Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    89667-40-3
  • Formula Weight
    281.35
  • Molecular Formula
    C18H19NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=C\CCCCC(O)=O)(\C1=CC=CC=C1)/C=2C=CC=NC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • OBE022

    OBE022 is a potent, highly selective, orally active antagonist of the contractile PGF2α prostaglandin receptor with Kb of 5.9 nM.

  • EP2 receptor antagon...

    EP2 receptor antagonist-2 (CID891729) is a compound that blocks EP2 receptor activation by PGE2 and reduces lactate dehydrogenase (LDH) release induced by N-methyl-D-aspartate (NMDA).

  • Secoxyloganin

    Secoxyloganin possesses a hepato-protective effect. Secoxyloganin possesses antibacterial activity.

Sign In Join Free